Roberto D’Amico

Active 1978–2025

Also published as
Roberto D'Amico · Roberto D'amico
109
Papers
35,466
Citations
64
h-index
100
i10-index

Citations

Citations per year for Roberto D’Amico1882: 1 citations1916: 1 citations1930: 1 citations1971: 1 citations1977: 1 citations1980: 1 citations1984: 3 citations1985: 2 citations1986: 2 citations1987: 6 citations1988: 6 citations1989: 4 citations1990: 3 citations1991: 13 citations1992: 13 citations1993: 11 citations1994: 9 citations1995: 15 citations1996: 13 citations1997: 14 citations1998: 19 citations1999: 21 citations2000: 28 citations2001: 40 citations2002: 49 citations2003: 45 citations2004: 76 citations2005: 121 citations2006: 155 citations2007: 174 citations2008: 172 citations2009: 216 citations2010: 190 citations2011: 208 citations2012: 216 citations2013: 201 citations2014: 222 citations2015: 195 citations2016: 232 citations2017: 180 citations2018: 140 citations2019: 528 citations2020: 579 citations2021: 548 citations2022: 418 citations2023: 271 citations2024: 441 citations2025: 200 citations2026: 6 citations1883–1915: no citations, so these years are not shown1917–1929: no citations, so these years are not shown1931–1970: no citations, so these years are not shown1972–1976: no citations, so these years are not shown1978–1979: no citations, so these years are not shown1981–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,799 citing papers, 19.3% of this breakdownUnited Kingdom: 1,201 citing papers, 12.9% of this breakdownItaly: 689 citing papers, 7.4% of this breakdownCanada: 513 citing papers, 5.5% of this breakdownChina: 448 citing papers, 4.8% of this breakdownAustralia: 438 citing papers, 4.7% of this breakdownGermany: 387 citing papers, 4.1% of this breakdownNetherlands: 355 citing papers, 3.8% of this breakdownFrance: 298 citing papers, 3.2% of this breakdownSpain: 266 citing papers, 2.9% of this breakdownSwitzerland: 221 citing papers, 2.4% of this breakdownBelgium: 171 citing papers, 1.8% of this breakdown
0%19.3%Other 27.2%

Fields

  • Medicine53.1%
  • Social Sciences13.6%
  • Biochemistry, Genetics and Molecular Biology6.9%
  • Health Professions4.2%
  • Nursing3.8%
  • Psychology2.7%
  • Other15.7%

Topics

  • HER2/EGFR in Cancer Research1.7%
  • Breast Cancer Treatment Studies1.5%
  • Multiple Sclerosis Research Studies1.1%
  • Meta-analysis and systematic reviews1%
  • Selenium in Biological Systems1%
  • Tuberculosis Research and Epidemiology1%
  • Other92.7%

Coauthors

All papers

Open in search
  1. Discipline and Punish: The Birth of the Prison

    Authors: - Telos 1978 cited by 19,561

  2. Evaluating non-randomised intervention studies

    Authors: , , , , , , , - Health Technology Assessment 2003 cited by 2,926

  3. Selenium for preventing cancer

    Authors: , , , , , , , , , - Cochrane Database of Systematic Reviews 2018 cited by 621

  4. Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 74

  5. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study

    Authors: , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 273

  6. Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2023 cited by 151

  7. Children and adolescents with ADHD followed up to adulthood: a systematic review of long-term outcomes

    Authors: , , , , , , , - Acta Neuropsychiatrica 2021 cited by 141

  8. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Schettini, Patricia Villagrasa, Lisa A. Carey, Charles M. Perou, Federico Piacentini, Roberto D’Amico, Enrico Tagliafico, Joel S. Parker, PierFranco Conte - The Lancet Oncology 2020 cited by 75

  9. Trastuzumab containing regimens for early breast cancer

    Authors: , , , , , , - Cochrane Database of Systematic Reviews 2012 cited by 607

  10. The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis

    Authors: , , , - International Journal of Cardiology 2016 cited by 174

  11. Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation

    Authors: , , , , , - Cochrane Database of Systematic Reviews 2021 cited by 78

  12. FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , - Frontiers in Neurology 2019 cited by 75

  13. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

    Authors: , , , , - Cochrane Database of Systematic Reviews 2015 cited by 212

  14. Indirect comparisons of competing interventions

    Authors: , , , , , , , - Health Technology Assessment 2005 cited by 685

  15. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2010 cited by 157

  16. Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto D’Amico, Valentina Guarneri - Annals of Oncology 2018 cited by 155

  17. Short-term and long-term effects of tibolone in postmenopausal women

    Authors: , , , , , , , , , , - Cochrane Database of Systematic Reviews 2016 cited by 188

  18. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)

    Authors: , , , , , , , , , , , , , , , , , , - BMJ Open 2019 cited by 66

  19. Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Liver Transplantation 2023 cited by 22

  20. Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 cited by 96

  21. Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 41

  22. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care

    Authors: , , , , , - Cochrane Database of Systematic Reviews 2009 cited by 191

  23. Rapamycin treatment for amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , - Medicine 2018 cited by 126

  24. Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maura Servida, Gabriele Siciliano, Giuliano Tomelleri, Rossella Tupler - Brain 2013 cited by 126